Company Filing History:

6 out of 16,338

E.i. Dupont De Nemours and Company

patents

4 out of 206

The Dupont Merck Pharmaceutical Company

patents

Years Active: 1982-1995

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5434264 - .alpha.,.alpha.-disubstituted aromatics and heteroaromatics as cognition (1995-07-18),

2. 5300642 - .alpha., .alpha.-disubstituted aromatics and heteroaromatics as (1994-04-05),

3. 5173489 - .alpha.,.alpha.-disubstituted aromatics and heteroaromatics as cognition (1992-12-22),

4. 5171745 - Method of treating neurological dysfunction using neutrotransmitter (1992-12-15),

5. 4990617 - N-oxide prodrug derivatives of 3-hydroxy morphinans and partial (1991-02-05),

6. 4876259 - 3,3-disubstituted indolines (1989-10-24),

7. 4760083 - 3,3-disubstituted indolines (1988-07-26),

8. 4722928 - N-oxide prodrug derivatives of 3-hydroxy morphinans and partial (1988-02-02),

9. 4355041 - 4,5-Bis-(4-fluorophenyl)-1-(4-nitrobenzyl (1982-10-19),

10. 4322426 - 17-Substituted-6-desoxy-7,8-dihydro-6.alpha.-methylnoroxymorphone (1982-03-30),

Title: The Innovations of Melvyn J Myers

Introduction

Melvyn J Myers is a distinguished inventor based in Wilmington, DE, who has made significant contributions to the field of cognitive health through his innovative patents. With a total of 10 patents to his name, Myers has developed groundbreaking compounds aimed at treating cognitive deficiencies and neurological dysfunctions in mammals.

Latest Patents

Melvyn J Myers' latest patents focus on the application of alpha, alpha-disubstituted aromatics and heteroaromatics. These compounds are notable for their efficacy in treating cognitive deficiencies or neurological dysfunctions. The patented formula comprises compounds that include components represented as: ##STR1## or a salt thereof. Notably, X and Y in the formula are configured to form a saturated or unsaturated carbocyclic or heterocyclic first ring, with a specified carbon in the ring being alpha to at least one additional aromatic or heteroaromatic ring fused to the first ring.

Career Highlights

Throughout his career, Melvyn J Myers has been associated with prestigious companies, including E.I. DuPont De Nemours and Company and the DuPont Merck Pharmaceutical Company. His work in these organizations has allowed him to contribute to advancements in pharmaceuticals and cognitive health, facilitating a better understanding of chemical compounds and their therapeutic applications.

Collaborations

In addition to his professional achievements, Melvyn has collaborated with esteemed coworkers including Victor J Nickolson and Richard A Earl. These partnerships have played a vital role in enhancing the research and development of innovative solutions in pharmacology and cognitive science.

Conclusion

Melvyn J Myers is a notable inventor whose work continues to influence the treatment of cognitive impairments in mammals. With his impressive patent portfolio and collaborative efforts, he has made lasting contributions to the fields of innovation and science, paving the way for future advancements in cognitive health.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.